Cancer screening in hospitalized ischemic stroke patients: a multicenter study focused on multiparametric analysis to improve management of occult cancers

Feigin VL, Owolabi MO. Pragmatic solutions to reduce the global burden of stroke: a world stroke organization-lancet neurology commission. Lancet Neurol. 2023;22(12):1160–206. https://doi.org/10.1016/s1474-4422(23)00277-6.

Article  PubMed  Google Scholar 

Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. https://doi.org/10.1016/s1474-4422(21)00252-0.

Navi BB, Iadecola C. Ischemic stroke in cancer patients: a review of an underappreciated pathology. Ann Neurol. 2018;83(5):873–83. https://doi.org/10.1002/ana.25227.

Article  PubMed  PubMed Central  Google Scholar 

Chae WH, Vössing A, Li Y, et al. Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center. Ther Adv Neurol Disord. 2023;16:17562864231207508. https://doi.org/10.1177/17562864231207508.

Article  PubMed  PubMed Central  Google Scholar 

Seystahl K, Hug A, Weber SJ, et al. Cancer is associated with inferior outcome in patients with ischemic stroke. J Neurol. 2021;268(11):4190–202. https://doi.org/10.1007/s00415-021-10528-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costamagna G, Hottinger A, Milionis H, et al. Clinical and demographic characteristics, mechanisms, and outcomes in patients with acute ischemic stroke and newly diagnosed or known active cancer. Neurology. 2023;100(24):e2477–89. https://doi.org/10.1212/wnl.0000000000207341.

Article  CAS  PubMed  Google Scholar 

Dearborn JL, Urrutia VC, Zeiler SR. Stroke and cancer- a complicated relationship. J Neurol Transl Neurosci. 2014;2(1):1039.

PubMed  PubMed Central  Google Scholar 

Castro HHG, Alencar AP, Bensenor IM, Lotufo PA, Goulart AC. Multimorbidities are associated to lower survival in ischaemic stroke: results from a Brazilian Stroke Cohort (EMMA Study). Cerebrovasc Dis. 2017;44(3–4):232–9. https://doi.org/10.1159/000479827.

Article  PubMed  Google Scholar 

Lin J, Wu S, Xu R, et al. Clinical Characteristics and risk factors of lung cancer-associated acute ischemic stroke. Biomed Res Int. 2019;2019:6021037. https://doi.org/10.1155/2019/6021037.

Article  PubMed  PubMed Central  Google Scholar 

Rioux B, Touma L, Nehme A, Gore G, Keezer MR, Gioia LC. Frequency and predictors of occult cancer in ischemic stroke: a systematic review and meta-analysis. Int J Stroke. 2021;16(1):12–9. https://doi.org/10.1177/1747493020971104.

Article  PubMed  Google Scholar 

Wang W, Yan Y, Guo Z, et al. All around suboptimal health - a joint position paper of the suboptimal health study consortium and european association for predictive preventive and personalised medicine. EPMA J. 2021;12(4):403–33. https://doi.org/10.1007/s13167-021-00253-2.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Potuznik P, Polivka J Jr, et al. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach. EPMA J. 2022;13(4):535–45. https://doi.org/10.1007/s13167-022-00307-z.

Article  PubMed  PubMed Central  Google Scholar 

Navi BB, Kasner SE, Elkind MSV, Cushman M, Bang OY, DeAngelis LM. Cancer and embolic stroke of undetermined source. Stroke. 2021;52(3):1121–30. https://doi.org/10.1161/strokeaha.120.032002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang J, Shang X, Zhao J, et al. Score for predicting active cancer in patients with ischemic stroke: a retrospective study. Biomed Res Int. 2021;2021:5585206. https://doi.org/10.1155/2021/5585206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Selvik HA, Bjerkreim AT, Thomassen L, Waje-Andreassen U, Naess H, Kvistad CE. When to screen ischaemic stroke patients for cancer. Cerebrovasc Dis. 2018;45(1–2):42–7. https://doi.org/10.1159/000484668.

Article  PubMed  Google Scholar 

Seystahl K, Gramatzki D, Wanner M, et al. A risk model for prediction of diagnosis of cancer after ischemic stroke. Sci Rep. 2023;13(1):111. https://doi.org/10.1038/s41598-022-26790-y.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand. 2009;119(1):1–16. https://doi.org/10.1111/j.1600-0404.2008.01059.x.

Article  CAS  PubMed  Google Scholar 

Kubatka P, Mazurakova A, Koklesova L, et al. Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine. EPMA J. 2022;13(3):407–31. https://doi.org/10.1007/s13167-022-00293-2.

Article  PubMed  PubMed Central  Google Scholar 

Polivka J Jr, Kralickova M, Polivka J, Kaiser C, Kuhn W, Golubnitschaja O. Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? EPMA J. 2017;8(2):119–27. https://doi.org/10.1007/s13167-017-0087-5.

Article  PubMed  PubMed Central  Google Scholar 

Nouh AM, Staff I, Finelli PF. Three Territory Sign: an MRI marker of malignancy-related ischemic stroke (Trousseau syndrome). Neurol Clin Pract. 2019;9(2):124–8. https://doi.org/10.1212/CPJ.0000000000000603.

Article  PubMed  PubMed Central  Google Scholar 

Gon Y, Okazaki S, Terasaki Y, et al. Characteristics of cryptogenic stroke in cancer patients. Ann Clin Transl Neurol. 2016;3(4):280–7. https://doi.org/10.1002/acn3.291.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grazioli S, Paciaroni M, Agnelli G, et al. Cancer-associated ischemic stroke: a retrospective multicentre cohort study. Thromb Res. 2018;165:33–7. https://doi.org/10.1016/j.thromres.2018.03.011.

Article  CAS  PubMed  Google Scholar 

Quintas S, Rogado J, Gullon P, et al. Predictors of unknown cancer in patients with ischemic stroke. J Neurooncol. 2018;137(3):551–7. https://doi.org/10.1007/s11060-017-2741-0.

Article  PubMed  Google Scholar 

Lee MJ, Chung JW, Ahn MJ, et al. Hypercoagulability and mortality of patients with stroke and active cancer: the OASIS-CANCER study. J Stroke. 2017;19(1):77–87. https://doi.org/10.5853/jos.2016.00570.

Article  PubMed  Google Scholar 

Kono T, Ohtsuki T, Hosomi N, et al. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Geriatr Gerontol Int. 2012;12(3):468–74. https://doi.org/10.1111/j.1447-0594.2011.00796.x.

Article  PubMed  Google Scholar 

Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6(7):611–9. https://doi.org/10.1016/s1474-4422(07)70170-9.

Article  PubMed  Google Scholar 

Han H, Guo W, Shi W, et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep. 2017;7:44877. https://doi.org/10.1038/srep44877.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Liang Z, Xie B, Li J, et al. Hypertension and risk of prostate cancer: a systematic review and meta-analysis. Sci Rep. 2016;6:31358. https://doi.org/10.1038/srep31358.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif